Michael Byers is an accomplished leader in the field of regenerative medicine and cellular therapies, serving as President, CEO, and Founder of Tooth Bank, LLC since February 2014, where the focus is on affordable dental stem cell solutions. Byers also contributes to AABB as a Committee Member of the Cellular Therapies Accreditation Program Unit and as HCT/Ps Lead Assessor, ensuring compliance with the highest standards of care. In addition, Byers founded Cryopoint in January 2012, providing biorepository services, and co-founded RenovoCyte, LLC, focusing on multipotent stromal cell therapy in veterinary medicine, as well as VialCo, LLC, known for its innovative Closed System Cryovials. Previous experience includes a leadership role at General BioTechnology, LLC, and research coordination at Eli Lilly. Byers holds an MBA in International Business and a BS in Biology from Purdue University.
This person is not in any teams
This person is not in any offices